Beta-cell deterioration--prospects for reversal or prevention.
Finegood
D T
DT
Simon Fraser University, School of Kinesiology, Room K9625, Burnaby, British Columbia, Canada, V5A 1S6. finegood@sfu.ca
Topp
B G
BG
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D016923:Cell Death / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D006801:Humans; D007333:Insulin Resistance; D007515:Islets of Langerhans / Q000187:drug effects / Q000503:physiopathology*; D008055:Lipids / Q000097:blood; D051381:Rats; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists; D000077154:Rosiglitazone; D013844:Thiazoles / Q000494:pharmacology; D045162:Thiazolidinediones; D014157:Transcription Factors / Q000819:agonists
D001786:Blood Glucose; D008055:Lipids; D018160:Receptors, Cytoplasmic and Nuclear; D013844:Thiazoles; D045162:Thiazolidinediones; D014157:Transcription Factors; D000077154:Rosiglitazone